Conference
Efficacy and Safety of Romosozumab Among Postmenopausal Women With Osteoporosis and Mild‐to‐Moderate Chronic Kidney Disease
Abstract
Patients with osteoporosis and chronic kidney disease (CKD) are at increased risk of fracture and associated negative outcomes, including increased mortality. The present post hoc analysis of two randomized, multicenter, phase 3 clinical trials-Fracture Study in Postmenopausal Women with Osteoporosis (FRAME) and Active-Controlled Fracture Study in Postmenopausal Women with Osteoporosis at High Risk (ARCH)-investigated the efficacy and safety of …
Authors
Miller PD; Adachi JD; Albergaria B; Cheung AM; Chines AA; Gielen E; Langdahl BL; Miyauchi A; Oates M; Reid IR
Volume
37
Pagination
pp. 1437-1445
Publisher
Oxford University Press (OUP)
Publication Date
December 1, 2020
DOI
10.1002/jbmr.4563
Conference proceedings
Journal of Bone and Mineral Research
Issue
8
ISSN
0884-0431